ShareValue scores for ALINS.PA: Valuation 47, Quality 42, Growth 56, Health 50.

Intrasense logo

ALINS.PA
Euronext Paris

Intrasense

€0.22(-1.36%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 17%
Valuation
47
Fair Value
Price vs Value
Quality
42
Moderate
Business Strength
Growth
56
Moderate
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
56
Neutral
Price Trend

Company Details

About

Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026